Bristol Myers Squibb · 1 day ago
Senior Specialist, Investigations, Cell Therapy in Devens, MA
Devens, MA
Full-time
Onsite
Mid, Senior Level
$88K/yr - $107K/yr
2+ years expBristol Myers Squibb is a leader in cell therapy, committed to transforming patients' lives through science. The Senior Specialist, Investigations, Cell Therapy will provide investigation leadership at the Devens Cell Therapy Facility, focusing on root cause analysis and corrective actions.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Conducting and managing the resolution of root cause investigations, including impact assessments, and CAPAs as a Lead Investigator
Collaborating with many different groups/organizations as a Lead Investigator including Process Engineering and Support, Engineering and Facilities, Manufacturing Operations, Quality Assurance, and Quality Control
Proactively managing the progression of investigations and CAPAs to timely and compliant closure per established KPIs
Presentation of investigation findings to key stakeholders and site senior management
Use of Quality Risk Management and Operational Excellence principles to facilitate risk-based decision-making, drive continuous improvement, and eliminate waste
Ensuring safe and compliant cGMP operations and maintaining permanent inspection readiness; Actively supporting regulatory inspections
Qualification
Required
Knowledge of science generally attained through studies resulting in a Bachelor's degree in science, engineering, biochemistry or related discipline plus 2-4 years' experience in biopharmaceutical operations, or its equivalent is required
Experience utilizing root cause analysis/OPEX tools and identifying corrective and preventative actions
Excellent verbal/written communication skills and ability to influence at all levels
Ability to think strategically, and to translate strategy into action
Ability to prioritize and provide clear direction to team members in a highly dynamic environment
Preferred
Experience with Operational Excellence and Lean Manufacturing
Experience in cell therapy, biologics, or vaccine manufacturing/support
Experience in cGMP's and multi-national biopharmaceutical/cell therapy regulations
Benefits
Health Coverage Medical, pharmacy, dental, and vision care.
Wellbeing Support Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Eligibility Disclosure The summer hours program is for United States (U.S.) office-based employees due to the unique nature of their work. Summer hours are generally not available for field sales and manufacturing operations and may also be limited for the capability centers. Employees in remote-by-design or lab-based roles may be eligible for summer hours, depending on the nature of their work, and should discuss eligibility with their manager.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
2026-01-07
2026-01-07
2026-01-07
Company data provided by crunchbase